Epidemiology and antimicrobial resistance patterns of Aeromonas species in Europe, 2020-2024 (AEuROMONAS) Matteo Boattini, Paulo Bastos, Konstantina Gartzonika, Eirini Christaki, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Nikolaos Giormezis, Gergana Lengerova, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Antonija Saskor, Karla Milanovic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Krajčíková, Anezka Gryndlerova, Pavel Drevinek, Miroslava Htoutou Sedláková, Milan Kolář, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Małgorzata Brauncajs, Filip Bielec, Dominika Seliga-Gąsior, Edyta Podsiadly, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Sara Posadas-Cantera, Mohamed Tarek Badr, Tim Kintzinger, Frieder Schaumburg, Philipp Thelen, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Katharina Hoffmann, Achim J. Kaasch, Damien Jacot, Gilbert Greub, Jessica Landi, Simone Ambretti, Sara Comini, Sofia Chiatamone Ranieri, Enrica Serretiello, Gianluigi Franci, Teresa Fasciana, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, Gregory Strubbe, Stien Vandendriessche, Pauline Rabeau, Stéphane Corvec, Damien Dubois, Pauline Floch, Delphine Chainier, Olivier Barraud, Assaf Mizrahi, Célia Bacho, Coralie Bouchiat, Tayssir Fatah, Hélène Marchandin, Vincent Jean-Pierre, Saied Ali, Sinead O’ Donnell, Maeve Doyle, Zachary Ramsamaroo, Clarice Egan, Sinead McNicholas, Kristján Orri Helgason, Betigül Öngen, Bahar Akgün Karapınar, Özlem Oyardi, Burak Aksu, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gilarranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Yuliya Volovetska, José Melo Cristino, Cristina Costa, Gabriele Bianco Diagnostic Microbiology and Infectious Disease, 2026
Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides Antonia D'Aniello, Veronica Folliero, Roberto Bello-Madruga, Vincenzo Mazzarella, Alessandra Del Bene, Federica Dell’Annunziata, Ilaria Cosimato, Flora Salzano, Ida De Chiara, Milena Della Gala, Roberto Cutolo, Martina Torino, Salvatore Mottola, Anna Messere, Lidia Muscariello, Sandro Cosconati, David Andreu, Marc Torrent Burgas, Gianluigi Franci, Salvatore Di Maro European Journal of Medicinal Chemistry, 2026 Antimicrobial peptides (AMPs) show great therapeutic potential due to their unique mechanism of action that guarantees broad-spectrum efficacy and limits bacterial antibiotic resistance. However, challenges such as limited stability and cytotoxicity toward host cells still limit their clinical translation, highlighting the need for new approaches, such as size reduction and lipid conjugation, to enhance their efficacy, cell penetration, stability, and safety. Herein, we report the de novo design of a library of ultra-short lipopeptides based on a rigid l -Arg– l -Pro– l -Arg core, conceived to control conformational restriction and amphiphilic organization rather than mimicking longer natural AMPs. The compounds were synthesized and preliminarily evaluated in vitro against three gram-negative and three gram-positive strains. Systematic modulation of lipid positioning and linker orientation in this minimal scaffold led to the identification of promising candidates displaying MIC values in the low-μM range against both gram-negative and gram-positive bacteria. Of the newly developed compounds, 15 exhibited optimal lipophilicity, excellent human-serum stability and a favourable safety profile, showing only low to moderate toxicity toward renal, hepatic, and red blood cells. Additionally, 15 proved effective in reducing S. aureus biofilm formation and showed strong activity against five clinical isolates. It acts as a bacteriostatic agent by perturbing bacterial membrane integrity, positioning it as a promising starting point for the development of a new class of chemotypes that could offer an alternative strategy for treating infections caused by this gram-positive pathogen. • A small set of short lipopeptides with an Arg–Pro–Arg core was developed, showing broad-spectrum antimicrobial activity. • 15 strongly inhibits the growth of S. aureus , including drug-resistant clinical strains, and showed a favorable selectivity index • 15 perturbed bacterial membranes and effectively disrupts preformed S. aureus biofilm leading to bacteriostatic effects. • 15 represents a promising starting point for developing small lipopeptides to treat persistent infections.
Minor non-fermenting Gram-negative bacilli in Europe, 2020–2024 (MINOFEu) Gabriele Bianco, Paulo Bastos, Konstantina Gartzonika, Eirini Christaki, Viktoria Eirini Mavromanolaki, Sofia Maraki, Anastasia Spiliopoulou, Nikolaos Giormezis, Gergana Lengerova, Yordan Kalchev, Ana Budimir, Branka Bedenić, Zana Rubic, Antonija Saskor, Karla Milanovic, Monica Licker, Corina Musuroi, Emese Juhász, Katalin Kristóf, Mateja Pirs, Ivana Velimirovic, Michael Berktold, Adriána Krajčíková, Anezka Gryndlerova, Pavel Drevinek, Miroslava Htoutou Sedláková, Milan Kolář, Monika Brzychczy-Wloch, Aldona Olechowska-Jarząb, Małgorzata Brauncajs, Filip Bielec, Dominika Seliga-Gąsior, Edyta Podsiadly, Kristian Riesbeck, Hanna-Sofia Andersson, Tone Tønjum, Johan Christian Berild, Truls Michael Leegaard, Asger Nellemann Rasmussen, Kristian Schønning, Stefan Glöckner, Jürgen Rödel, Sara Posadas-Cantera, Mohamed Tarek Badr, Tim Kintzinger, Frieder Schaumburg, Philipp Thelen, Axel Hamprecht, Anna Dudakova, Jonathan Jantsch, Katharina Hoffmann, Achim J. Kaasch, Damien Jacot, Gilbert Greub, Jessica Landi, Simone Ambretti, Sara Comini, Sofia Chiatamone Ranieri, Enrica Serretiello, Gianluigi Franci, Teresa Fasciana, Rogier Schade, Erlangga Yusuf, Stefanie van Kleef-van Koeveringe, Sarah Vandamme, Alexia Verroken, Hector Rodriguez-Villalobos, Gregory Strubbe, Stien Vandendriessche, Pauline Rabeau, Stéphane Corvec, Damien Dubois, Clémence Massip, Delphine Chainier, Olivier Barraud, Assaf Mizrahi, Célia Bacho, Coralie Bouchiat, Tayssir Fatah, Hélène Marchandin, Vincent Jean-Pierre, Saied Ali, Sinead O’Donnell, Maeve Doyle, Zachary Ramsamaroo, Clarice Egan, Sinead McNicholas, Kristján Orri Helgason, Betigül Öngen, Bahar Akgün Karapınar, Özlem Oyardı, Burak Aksu, Javier Colomina-Rodriguez, Ignacio Torres, Raul Gilarranz Luengo, Maria Nieves Larrosa Escartín, Maria Belen Viñado Perez, Ana Verónica Halperin, Rafael Cantón, Miguel Seruca, Vasco Santos Mendes, Yuliya Volovetska, José Melo Cristino, Cristina Costa, Matteo Boattini International Journal of Antimicrobial Agents, 2026
Micro- and Nanoplastics as Disruptors of Digestive and Hepatopancreatic Homeostasis: Insights into the Plastic-Gut-Liver Axis Nicoletta Capuano, Martina Lombardi, Noemi Cafà, Marianna Marino, Flora Salzano, Federica Scalia, Raffaele Marfella, Giovanni Villone, Francesco Cappello, Marta Anna Szychlinska, Gianluigi Franci, Antonietta Santoro, Luca Rinaldi International Journal of Molecular Sciences, 2026 Micro- and nanoplastics (MPs/NPs) have emerged as pervasive environmental contaminants with increasing implications for human health, particularly within the digestive system. This review critically examines the role of MPs/NPs as disruptors of gastrointestinal and liver homeostasis through the lens of the plastic–gut–liver axis. We synthesize current evidence on primary exposure routes—including ingestion, inhalation, dermal contact, and transplacental transfer—and highlight their intestinal uptake, systemic dissemination, and tissue accumulation. Mechanistically, MPs/NPs compromise intestinal barrier integrity, promote oxidative stress, and induce microbiota dysbiosis, facilitating the translocation of microbial-derived signals to the liver via the portal circulation. This process triggers inflammatory signaling cascades, metabolic reprogramming, and immune dysregulation, contributing to hepatic steatosis, insulin resistance, and potential carcinogenic processes. Emerging evidence also implicates pancreatic dysfunction and β-cell stress within a broader gut–liver axis context. We further discuss the systemic propagation of MPs/NPs-induced dysbiosis along multi-organ axes, including gut–lung and gut–brain interactions. Despite robust preclinical data, human evidence remains limited due to methodological heterogeneity and the lack of standardized biomarkers. This review underscores critical knowledge gaps and emphasizes the need for integrative, translational approaches to clarify long-term health risks and inform regulatory strategies within the environmental exposome framework.
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment Claudia Russo, Clorinda Fusco, Fortunata Carbone, Teresa Micillo, Claudia La Rocca, Giusy De Rosa, Vincenzo Di Marino, Kristyna Ruggiero, Federica Garziano, Francesco Perna, Carla Zannella, Massimiliano Galdiero, Gianluigi Franci, Roberta Lanzillo, Vincenzo Brescia Morra, Rachele Bigi, Gianmarco Abbadessa, Simona Bonavita, Marco Salvetti, Marcello Moccia, Claudio Procaccini, Giuseppe Matarese Clinical Immunology, 2026
Applications, Training Requirements, and Challenges in the Implementation of Ultrasonography in Nursing Practice: A Scoping Review Vincenzo Andretta, Carloluigi Bonetti, Ivan Rubbi, Biagio Santella, Rosanna Sorrentino, Gianluigi Franci, Marco Cascella, Valentina Cerrone Journal for Vascular Ultrasound, 2026 Introduction: The use of ultrasound in nursing practice is constantly expanding with applications in numerous clinical settings, for supporting diagnostic assessments, procedural guidance, monitoring, and verification of device placement. However, the patterns of employment, the skills required, and the impact on care outcomes are heterogeneous. Objective: To map the clinical applications, outcomes, training requirements, and main barriers and facilitators to the implementation of nurse-performed ultrasound in different health care settings. Methods: A scoping review was conducted according to the Arksey and O’Malley framework, integrated with the Joanna Briggs Institute indications, and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. The research was conducted in PubMed, Scopus, Web of Science, and Google Scholar without time limits. Studies describing the use of ultrasound by nurses in any clinical setting were included. The data were extracted using a standardized form and narratively synthesized into thematic domains. Results: Twelve studies met the inclusion criteria, including randomized trials, observational, qualitative studies, and reviews. Ultrasonography was used for (1) diagnostic evaluations, including abdominal aorta, bladder volume, and lung; (2) procedural guidance, mainly for peripheral venous access and catheter tip localization; (3) clinical monitoring, such as hemodynamic evaluation and enteral feeding management; (4) verification of device placement. Studies reported improvements in first-time success, suggested fewer procedural complications, increased diagnostic accuracy, and increased patient satisfaction. Among the barriers are insufficient training, limited availability of devices, and cultural resistance. Facilitators include structured training programs, institutional support, and shared protocols. Conclusions: Ultrasound used by nurses shows a reported clinical impact, improving safety, accuracy, and continuity of care. Wider adoptability requires standardized training, access to technologies, and integration into interprofessional paths. Future studies should evaluate long-term outcomes and applications in territorial and home settings.
Emerging Therapeutic Approaches for Modulating the Intestinal Microbiota Ilaria Cosimato, Annalisa Brescia, Gianluigi Franci, Vincenzo Casolaro, Veronica Folliero Pharmaceutics, 2026 Background/Objectives: The gut microbiota is increasingly recognized as a key determinant of human health, playing a vital role in metabolism, immunity, and disease susceptibility. Dysbiosis, or microbial imbalance, is associated with gastrointestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and Clostridioides difficile infection (CDI), as well as extraintestinal conditions, including obesity, cardiovascular disease, and neuropsychiatric disorders. This review aims to provide an updated overview of emerging therapeutic strategies to modulate the gut microbiota to restore eubiosis and improve health outcomes. Methods: A narrative review of recent literature was conducted, focusing on preclinical and clinical studies investigating microbiota-targeted therapies. The review primarily covers innovative interventional approaches, including fecal microbiota transplantation (FMT), bacterial consortium transplantation (BCT), bacteriophage therapy and outer membrane vesicles (OMVs). Results: Evidence supports the role of probiotics, prebiotics, and synbiotics in remodeling microbial communities and improving host health, although their effects may be strain- and context-dependent. FMT has demonstrated high efficacy in the treatment of recurrent Clostridium difficile infections and is being studied for IBD, IBS and extraintestinal diseases, following the recent Food and Drug Administration approval of the first commercial FMT products. BCT offers a standardized alternative to donor-derived material, with early clinical successes such as FDA-approved SER-109. Phage therapy and OMVs represent promising frontiers, offering targeted microbial modulation and interactions with the immune system, although clinical data remain limited. Conclusions: Emerging gut microbiota modulation strategies offer new perspectives for precision medicine and could transform the prevention and treatment of many diseases, but further studies are needed to ensure their safety, standardization, and clinical application.
Linking Cancer Pain Features and Biosignals for Automatic Pain Assessment Marco Cascella, Francesco Perri, Alessandro Ottaiano, Mariachiara Santorsola, Maria Luisa Marciano, Fabiana Raffaella Rampetta, Monica Pontone, Anna Crispo, Francesco Sabbatino, Gianluigi Franci, Walter Esposito, Gennaro Cisale, Maria Romano, Francesco Amato, Amalia Scuotto, Vittorio Santoriello, Alfonso Maria Ponsiglione Cancers, 2026 Background: Pain remains one of the most debilitating and prevalent symptoms in cancer patients. However, assessment based solely on subjective self-report tools is limited by cognitive impairment and the heterogeneous nature of cancer pain. Since evidence on the ability of physiological biosignals to discriminate cancer pain intensity and pain phenotypes in real clinical settings remains limited, this study explored the potential of biosignals to discriminate between pain intensity and pain type. Methods: Electrodermal activity (EDA) and electrocardiogram (ECG) signals were recorded in cancer patients using the BITalino (r)evolution board (sampling frequency 1000 Hz). EDA was processed to extract skin conductance responses (SCRs) using continuous decomposition analysis (CDA) and trough-to-peak (TTP) methods. Heart rate variability (HRV) features were extracted in both time and frequency domains, including low frequency (LF), high frequency (HF), and the LF/HF ratio. Non-parametric Kruskal–Wallis tests were performed to compare biosignal parameters across pain intensity (Numeric Rating Scale, NRS: low 1–3; medium 4–6; and high 7–10) and pain types (nociceptive, neuropathic, mixed, and breakthrough cancer pain—BTCP). Results: Data from 61 patients were analyzed. For EDA, the maximum skin conductance response amplitude (MaxCDA) significantly differed across intensity groups (p = 0.037). Post hoc analysis showed a significant difference between the low- and high-intensity groups (p = 0.015), with the low-intensity group exhibiting a higher mean MaxCDA (0.063 µS) than the high-intensity group (0.024 µS). Several EDA parameters were significantly associated with pain type. The number of SCRs (TTP) (p = 0.015) and maximum SCR amplitude (TTP) (p = 0.040) were significantly lower in the mixed pain group compared with the nociceptive and neuropathic groups. No HRV parameters showed significant associations with pain intensity or pain type. BTCP did not significantly affect any biosignal parameters. Subgroup analyses showed that EDA features discriminating mixed pain were preserved in patients without bone metastases, BTCP, or high opioid burden, whereas no clinical variable modified the association between biosignals and pain intensity and type. Conclusions: In this investigation, selected EDA parameters were associated with cancer pain intensity and pain type, whereas heart rate variability measures did not show significant discrimination under the present methodological conditions. These findings suggest that EDA may provide complementary information on pain-related autonomic alterations in oncology patients. However, biosignals should not be considered standalone indicators of pain, and their interpretation requires integration with clinical variables and pharmacological context. Further studies adopting multimodal and longitudinal approaches are needed to clarify their role in automatic pain assessment in cancer care.
Sepsis management in the antimicrobial resistance era Silvano Esposito, Flora Salzano, Tiziana Ascione, Chiara D’Amore, Anna Maria Spera, Valeria Conti, Gianluigi Franci, Pasquale Pagliano Expert Review of Anti Infective Therapy, 2025
Antiviral Activity of the Marine Haptophyta Diacronema lutheri Eleonora Montuori, Annalisa Ambrosino, Gerardo Della Sala, Costanza Ragozzino, Gianluigi Franci, Carla Zannella, Anna De Filippis, Donatella de Pascale, Massimiliano Galdiero, Chiara Lauritano Marine Drugs, 2025
Cistus incanus: a natural source of antimicrobial metabolites Anna De Filippis, Vincenzo D’Amelia, Veronica Folliero, Carla Zannella, Gianluigi Franci, Massimiliano Galdiero, Antonio Di Loria, Carmen Laezza, Simona Maria Monti, Anna Lisa Piccinelli, Rita Celano, Maria Manuela Rigano Natural Product Research, 2025
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC Giovanna Polcaro, Luigi Liguori, Valentina Manzo, Annalisa Chianese, Giuliana Donadio, Alessandro Caputo, Giosuè Scognamiglio, Federica Dell’Annunziata, Maddalena Langella, Graziamaria Corbi, Alessandro Ottaiano, Marco Cascella, Francesco Perri, Margot De Marco, Jessica Dal Col, Giovanni Nassa, Giorgio Giurato, Pio Zeppa, Amelia Filippelli, Gianluigi Franci, Fabrizio Dal Piaz, Valeria Conti, Stefano Pepe, Francesco Sabbatino Molecular Cancer, 2024
Whole Genome Sequence Dataset of Mycobacterium tuberculosis Strains from Patients of Campania Region Veronica Folliero, Carlo Ferravante, Valentina Iovane, Annamaria Salvati, Laura Crescenzo, Rossella Perna, Giusy Corvino, Maria T. Della Rocca, Vittorio Panetta, Alessandro Tranfa, Giuseppe Greco, Teresa Baldoni, Ugo Pagnini, Emiliana Finamore, Giorgio Giurato, Giovanni Nassa, Mariagrazia Coppola, Luigi Atripaldi, Rita Greco, Annamaria D’Argenio, Maria Grazia Foti, Rosamaria Abate, Annalisa Del Giudice, Bruno Sarnelli, Alessandro Weisz, Giuseppe Iovane, Renato Pinto, Gianluigi Franci, Massimiliano Galdiero Scientific Data, 2024
Evaluation of antifungal spectrum of Cupferron against Candida albicans Francesca Palma, Marina Acunzo, Roberta Della Marca, Federica Dell’Annunziata, Veronica Folliero, Annalisa Chianese, Carla Zannella, Gianluigi Franci, Anna De Filippis, Massimiliano Galdiero Microbial Pathogenesis, 2024
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study L. Rinaldi, M. Lugarà, V. Simeon, F. Perrotta, C. Romano, C. Iadevaia, C. Sagnelli, L. Monaco, C. Altruda, M.C. Fascione, L. Restivo, U. Scognamiglio, N. Laganà, R. Nevola, G. Oliva, M.G. Coppola, C. Acierno, F. Masini, E. Pinotti, E. Allegorico, S. Tamburrini, G. Vitiello, M. Niosi, M.L. Burzo, G. Franci, A. Perrella, G. Signoriello, V. Frusci, S. Mancarella, G. Loche, G.F. Pellicano, M. Berretta, G. Calabria, L. Pietropaolo, F.G. Numis, N. Coppola, A. Corcione, R. Marfella, L.E. Adinolfi, A. Bianco, F.C. Sasso, I. de Sio Pulmonology, 2024
New Imidazolium Alkaloids with Broad Spectrum of Action from the Marine Bacterium Shewanella aquimarina Rosa Giugliano, Gerardo Della Sala, Carmine Buonocore, Carla Zannella, Pietro Tedesco, Fortunato Palma Esposito, Costanza Ragozzino, Annalisa Chianese, Maria Vittoria Morone, Valerio Mazzella, Laura Núñez-Pons, Veronica Folliero, Gianluigi Franci, Anna De Filippis, Massimiliano Galdiero, Donatella de Pascale Pharmaceutics, 2023
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania region of Italy Carlo Ferravante, Giuseppina Sanna, Viola Melone, Aurore Fromentier, Teresa Rocco, Ylenia D'Agostino, Jessica Lamberti, Elena Alexandrova, Giovanni Pecoraro, Pasquale Pagliano, Roberta Astorri, Aldo Manzin, Alessandro Weisz, Giorgio Giurato, Massimiliano Galdiero, Francesca Rizzo, Gianluigi Franci Journal of Medical Virology, 2022
Postmortem interval assessment by MALDI-TOF mass spectrometry analysis in murine cadavers Federica Dell’Annunziata, Francesca Martora, Maria Elena Della Pepa, Veronica Folliero, Livio Luongo, Serena Bocelli, Francesca Guida, Pasquale Mascolo, Carlo Pietro Campobasso, Sabatino Maione, Gianluigi Franci, Marilena Galdiero Journal of Applied Microbiology, 2022
DNA Mutations via Chern–Simons Currents Francesco Bajardi, Lucia Altucci, Rosaria Benedetti, Salvatore Capozziello, Maria Rosaria Del Sorbo, Gianluigi Franci, Carlo Altucci European Physical Journal Plus, 2021
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19 Elena Ciaglia, Valentina Lopardo, Francesco Montella, Carmine Sellitto, Valentina Manzo, Emanuela De Bellis, Teresa Iannaccone, Gianluigi Franci, Carla Zannella, Pasquale Pagliano, Paola Di Pietro, Albino Carrizzo, Carmine Vecchione, Valeria Conti, Amelia Filippelli, Annibale Alessandro Puca Journals of Gerontology Series A Biological Sciences and Medical Sciences, 2021
Gene transfer potential of outer membrane vesicles of gram‐negative bacteria Federica Dell’Annunziata, Veronica Folliero, Rosa Giugliano, Anna De Filippis, Cristina Santarcangelo, Viviana Izzo, Maria Daglia, Massimiliano Galdiero, Carla Renata Arciola, Gianluigi Franci International Journal of Molecular Sciences, 2021
Application of dendrimers for treating parasitic diseases Veronica Folliero, Carla Zannella, Annalisa Chianese, Debora Stelitano, Annalisa Ambrosino, Anna De Filippis, Marilena Galdiero, Gianluigi Franci, Massimiliano Galdiero Pharmaceutics, 2021
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study Celestino Sardu, Maria Consiglia Trotta, Biagio Santella, Nunzia D'Onofrio, Michelangela Barbieri, Maria Rosaria Rizzo, Ferdinando Carlo Sasso, Lucia Scisciola, Fabrizio Turriziani, Michele Torella, Michele Portoghese, Francesco Loreni, Simone Mureddu, Maria Antonietta Lepore, Massimiliano Galdiero, Gianluigi Franci, Veronica Folliero, Arianna Petrillo, Lara Boatti, Fabio Minicucci, Ciro Mauro, Paolo Calabrò, Marisa De Feo, Maria Luisa Balestrieri, Danilo Ercolini, Michele D'Amico, Giuseppe Paolisso, Marilena Galdiero, Raffaele Marfella Diabetes Research and Clinical Practice, 2021
SARS-CoV-2 vaccine development: Where are we? Massimiliano Galdiero, Massimiliano Galdiero, Veronica Folliero, Carla Zannella, Anna De Filippis, et al. European Review for Medical and Pharmacological Sciences, 2021
Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses Manjot Singh, Carla Zannella, Veronica Folliero, Rocco Di Girolamo, Francesco Bajardi, Annalisa Chianese, Lucia Altucci, Achille Damasco, Maria Rosaria Del Sorbo, Concetta Imperatore, Manuela Rossi, Mohammadhassan Valadan, Michela Varra, Alessandro Vergara, Guanluigi Franci, Massimiliano Galdiero, Carlo Altucci Frontiers in Bioengineering and Biotechnology, 2020
Current evidence on the ocular surface microbiota and related diseases Francesco Petrillo, Danilo Pignataro, Maria Annunziata Lavano, Biagio Santella, Veronica Folliero, Carla Zannella, Carlo Astarita, Caterina Gagliano, Gianluigi Franci, Teresio Avitabile, Marilena Galdiero Microorganisms, 2020
Sonoporation by microbubbles as gene therapy approach against liver cancer Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci Oncotarget, 2018
Comment on: MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma European Review for Medical and Pharmacological Sciences, 2018
Microbial Evaluation in Capsular Contracture of Breast Implants Marilena Galdiero, Fabio Larocca, Maria Rosaria Iovene, Martora Francesca, Gorizio Pieretti, Virginia D’Oriano, Gianluigi Franci, Giuseppe Ferraro, Francesco d’Andrea, Giovanni Francesco Nicoletti Plastic and Reconstructive Surgery, 2018
The intriguing journey of gH625-dendrimers A. Falanga, L. Lombardi, R. Tarallo, G. Franci, E. Perillo, L. Palomba, M. Galdiero, D. Pontoni, G. Fragneto, M. Weck, S. Galdiero Rsc Advances, 2017
Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein European Review for Medical and Pharmacological Sciences, 2016
Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis Aldo Giudice, Giovanni D’Arena, Anna Crispo, Mario Felice Tecce, Flavia Nocerino, Maria Grimaldi, Emanuela Rotondo, Anna Maria D’Ursi, Mario Scrima, Massimiliano Galdiero, Gennaro Ciliberto, Mario Capunzo, Gianluigi Franci, Antonio Barbieri, Sabrina Bimonte, Maurizio Montella Oxidative Medicine and Cellular Longevity, 2016
MePR: A novel human mesenchymal progenitor model with characteristics of pluripotency Marco Miceli, Gianluigi Franci, Carmela Dell'Aversana, Francesca Ricciardiello, Francesca Petraglia, Annamaria Carissimo, Lucia Perone, Giuseppe Maria Maruotti, Marco Savarese, Pasquale Martinelli, Massimo Cancemi, Lucia Altucci Stem Cells and Development, 2013
Uncovering common principles in protein export of malaria parasites Christof Grüring, Arlett Heiber, Florian Kruse, Sven Flemming, Gianluigi Franci, Sara F. Colombo, Elisa Fasana, Hanno Schoeler, Nica Borgese, Hendrik G. Stunnenberg, Jude M. Przyborski, Tim-Wolf Gilberger, Tobias Spielmann Cell Host and Microbe, 2012
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells Paola Bontempo, Luigi Mita, Antonella Doto, Marco Miceli, Angela Nebbioso, Ilaria Lepore, GianLuigi Franci, Roberta Menafra, Vincenzo Carafa, Mariarosaria Conte, Floriana De Bellis, Fabio Manzo, Vincenzo Di Cerbo, Rosaria Benedetti, Loredana D'Amato, Maria Marino, Alessandro Bolli, Giovanna Del Pozzo, Nadia Diano, Marianna Portaccio, Gustavo D Mita, Maria Teresa Vietri, Michele Cioffi, Ernesto Nola, Carmela Dell'Aversana, Vincenzo Sica, Anna Maria Molinari, Lucia Altucci Journal of Translational Medicine, 2009
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule Fabio Manzo, Angela Nebbioso, Marco Miceli, Mariarosaria Conte, Floriana De Bellis, Vincenzo Carafa, Gianluigi Franci, Francesco P. Tambaro, Lucia Altucci International Journal of Biochemistry and Cell Biology, 2009